Levothyroxine Sodium 20 ug / mL Injection 5 mL
NDC 63323-0885-10 is also written 63323088510, or 63323-885-10 (6332388510) in 10-digit form. Reference details for licensed healthcare facility review and verification.
| NDC 11 | 63323-0885-10 |
|---|---|
| Product NDC | 63323-0885 |
| Generic Drug Name | Levothyroxine Sodium |
| Brand Name | Levothyroxine Sodium |
| Manufacturer | Fresenius Kabi USA, LLC |
| Strength | 20 ug / mL |
| Dosage Form | Injection |
| Drug Type | Intravenous |
| Package Quantity | 1 Vial, Single-Dose |
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-885-10) / 5 mL in 1 VIAL, SINGLE-DOSE |
| Active Ingredients | Levothyroxine Sodium |
| Marketing Category | NDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
Levothyroxine Sodium 20 ug / mL Injection is tracked under NDC 63323-0885-10 and rolls up into product family 63323-0885. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.
- Package configuration: 1 Vial, Single-Dose.
- Manufacturer: Fresenius Kabi USA, LLC.
- Dosage form: Injection.
- Family size: 3 indexed presentations.
Click a tag to refine the catalog view around this product reference.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Alternate presentations in this family
These nearby package-level pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.
Drug Shortage Information
Documented shortage listings have referenced this NDC and levothyroxine sodium previously, indicating some recurrence, though the history is limited.
Drug Shortage Index family
View Levothyroxine Sodium Anhydrous in the Drug Shortage IndexCompare related NDC-level product references and family-level shortage context for Levothyroxine Sodium Anhydrous.This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
Levothyroxine Sodium 20 ug / mL Injection 5 mL, NDC 63323-0885-10, is a Fresenius Kabi USA, LLC 20 ug / mL injection presentation packaged as 1 Vial, Single-Dose. Historical public shortage information is available for this product reference.
NDC search formats
- Canonical NDC 11: 63323-0885-10
- Digits-only NDC 11: 63323088510
- Possible 10-digit display format: 63323-885-10 (6332388510)
Helpful product links
- Search by brand name: Levothyroxine Sodium
- NDC 11: 63323-0885-10
- Product family NDC: 63323-0885
- Compare related presentations: Levothyroxine Sodium 20 ug / mL Injection 5 mL, Levothyroxine Sodium 20 ug / mL Injection 5 mL
- VA classification code: HS851
- VA classification code description: THYROID SUPPLEMENTS
- CMOP ID: L0532
- VUID: 4002326
